A dynamic map for learning, communicating, navigating and improving therapeutic development

Affiliations

¹ Takeda Pharmaceuticals, Cambridge, Massachusetts 02142, USA.
² Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
³ Critical Path Institute, Tucson, Arizona 85718, USA.
⁴ Genetic Alliance, Washington, DC 20008, USA.
⁵ Stanford University, Stanford, California 94305, USA.
⁶ National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20817, USA.
⁷ Georgetown Preparatory School, North Bethesda, Maryland 20852, USA.

Comment

John Wagner et al. Nat Rev Drug Discov. 2018 Feb.

. 2018 Feb;17(2):150.

doi: 10.1038/nrd.2017.217. Epub 2017 Dec 22.

¹ Takeda Pharmaceuticals, Cambridge, Massachusetts 02142, USA.
² Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
³ Critical Path Institute, Tucson, Arizona 85718, USA.
⁴ Genetic Alliance, Washington, DC 20008, USA.
⁵ Stanford University, Stanford, California 94305, USA.
⁶ National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20817, USA.
⁷ Georgetown Preparatory School, North Bethesda, Maryland 20852, USA.

No abstract available

Comment on

How to improve R&D productivity: the pharmaceutical industry's grand challenge.
Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL. Paul SM, et al. Nat Rev Drug Discov. 2010 Mar;9(3):203-14. doi: 10.1038/nrd3078. Epub 2010 Feb 19. Nat Rev Drug Discov. 2010. PMID: 20168317 Review.